The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer
暂无分享,去创建一个
Pei-Fang Su | Nan-Haw Chow | N. Chow | Chung-Ta Lee | Jenq-Chang Lee | P. Lin | Peng-Chan Lin | Shao-Chieh Lin | Chung-Ta Lee | P. Su | Jenq‐Chang Lee | Shao‐Chieh Lin
[1] M. Mattei,et al. A novel putative receptor protein tyrosine kinase of the met family. , 1993, Oncogene.
[2] C. Heldin,et al. Dimerization of cell surface receptors in signal transduction , 1995, Cell.
[3] Parfrey,et al. bcl‐2 protein expression is associated with better prognosis in colorectal cancer , 1999, Histopathology.
[4] T. Tzai,et al. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder , 2005, British Journal of Cancer.
[5] M. Stella,et al. Cross-talk between the proto-oncogenes Met and Ron , 2000, Oncogene.
[6] E. Sabo,et al. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] V J Wielenga,et al. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. , 2000, The American journal of pathology.
[8] H. Wiley,et al. ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors* , 1999, The Journal of Biological Chemistry.
[9] C. Mcsherry,et al. Carcinoma of the Distal Large Bowel: 32‐Year Review of 1,026 Cases , 1966, Annals of surgery.
[10] Dong Wang,et al. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential , 2003, Oncogene.
[11] Roderick Turner,et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] P. Comoglio,et al. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype , 1996, Molecular and cellular biology.
[13] M. Greene,et al. Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function , 1990, Cell.
[14] Yuan Cheng,et al. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. , 2006, Cancer research.
[15] D. Seol,et al. Co‐expression and regulation of Met and Ron proto‐oncogenes in human hepatocellular carcinoma tissues and cell lines , 1997, Hepatology.
[16] E. Raso,et al. Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis , 2004, Clinical & Experimental Metastasis.
[17] M. H. Wang,et al. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines. , 2000, Experimental cell research.
[18] L. Trusolino,et al. Scatter-factor and semaphorin receptors: cell signalling for invasive growth , 2002, Nature Reviews Cancer.
[19] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[20] P. Sismondi,et al. Overexpression of the RON gene in human breast carcinoma , 1998, Oncogene.
[21] Helen H. W. Chen,et al. Prognostic Significance of Co-expression of RON and MET Receptors in Node-Negative Breast Cancer Patients , 2005, Clinical Cancer Research.
[22] D. Katsaros,et al. The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. , 2003, Experimental cell research.
[23] E. Leonard,et al. Identification of the ron gene product as the receptor for the human macrophage stimulating protein. , 1994, Science.
[24] M. Sliwkowski,et al. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. , 1994, The Journal of biological chemistry.
[25] K. Shimoda,et al. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer , 1991, Diseases of the colon and rectum.
[26] B. Peace,et al. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis , 2001, Oncogene.
[27] M. Weiser,et al. Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer , 2005, Clinical & Experimental Metastasis.
[28] Z. Han,et al. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. , 2003, Blood.
[29] A. Tarnawski,et al. Prostaglandins promote colon cancer cell invasion; signaling by cross‐talk between two distinct growth factor receptors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] T. Tzai,et al. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] E. Sabo,et al. Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer , 2004, Clinical Cancer Research.
[32] M. H. Wang,et al. Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells. , 2000, Carcinogenesis.
[33] M. Tsao,et al. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. , 1992, Oncogene.
[34] S. Hakomori,et al. Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.
[35] J. C. Lee,et al. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery. , 2002, European journal of cancer.